The OMEGA Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 328 participants.
Also called NCT01419171
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 328 participants
- Sponsor
- Registry
-
NCT01419171
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, France, Germany, Latvia, Netherlands, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01419171. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-08-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The OMEGA Clinical Trial
- Condition
- Atherosclerosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- OMEGA™ Monorail Coronary Stent System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01419171- Content hash
d9b4df7ef5c7e0fda11ff965be54a72c63c0443bbb00406ea163fe113cbe7be7